abstract |
FIELD: medicine; pharmaceuticals. n n SUBSTANCE: invention relates to a pharmaceutical composition, namely a capsule for the treatment of disorders associated with infection Helicobacter pylori (H. pylori). A single dose capsule for the treatment of infections associated with infection Helicobacter pylori (H. pylori), including a mixture of: a first immediate release dosage composition in the form of compressed mini-tablets containing amoxicillin and rifabutin, and a second delayed-release dosage composition in the form of compressed mini-tablets containing omeprazole and coated with an enteric coating. A method for treating a host against infection H. Pylori. n n EFFECT: above-described capsule can effectively treat disorders caused by Helicobacter pylori infection, by releasing drugs in a certain sequence. n 19 cl, 6 dwg, 21 tbl, 7 ex |